$1142.85
-7.00-0.61%
Last update: Oct 2, 7:59 PM
$1143.60
-6.25-0.54%
Eli Lilly and Co
LLYNYSE
Eli Lilly (LLY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Eli Lilly (LLY) last issued guidance on August 5, 2026 for fiscal year 2026. The company guided earnings per share in the range of $35.5 - $36.5, compared to a consensus EPS estimate of $36.12. Eli Lilly also guided revenue in the range of $85B - $87B for the period.
Compared to prior guidance, Eli Lilly maintained its EPS outlook from a previous range of $35.5 - $37. On the revenue side, the company raised its revenue forecast from a prior range of $82B - $85B.
Eli Lilly has issued 22 guidance updates between November 1, 2022 and August 5, 2026. During this period, the company raised its outlook 12 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.01 | $6.85 | $6.96 | $5.96 |
| Actual | $8.38 | $8.55 | $7.54 | $7.02 |
| Surprise | +39.4% | +24.8% | +8.33% | +17.8% |
| Revenue | ||||
| Estimate | $20.44B | $17.78B | $17.91B | $16.05B |
| Actual | $22.97B | $19.80B | $19.30B | $17.60B |
| Surprise | +12.4% | +11.4% | +7.74% | +9.69% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $9.86 | $10.13 | $9.70 | $10.40 |
| Revenue | ||||
| Consensus | $22.28B | $23.49B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $8.38 | $6.01 | 39.4 % |
| Q1 | Apr 30, 2026 | $8.55 | $6.85 | 24.8 % |
| Q4 | Feb 4, 2026 | $7.54 | $6.96 | 8.33 % |
| Q3 | Oct 30, 2025 | $7.02 | $5.96 | 17.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $22.97B | $20.44B | 12.4 % |
| Q1 | Apr 30, 2026 | $19.80B | $17.78B | 11.4 % |
| Q4 | Feb 4, 2026 | $19.30B | $17.91B | 7.74 % |
| Q3 | Oct 30, 2025 | $17.60B | $16.05B | 9.69 % |
